The global market for Amantadine HCl Oral was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Amantadine is a medication that has U.S. Food and Drug Administration approval for use both as an antiviral and an antiparkinsonian medication.

North American market for Amantadine HCl Oral is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Amantadine HCl Oral is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Amantadine HCl Oral include Zydus Pharmaceuticals, Mylan, Teva, Vertical Pharmaceuticals, Adamas Pharmaceuticals, Upsher-Smith, Sandoz, Mikart Pharmaceuticals, Pharmaceutical Associates, Inc. (PAI), Wockhardt Bio AG, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Amantadine HCl Oral, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amantadine HCl Oral.

The Amantadine HCl Oral market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Amantadine HCl Oral market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Amantadine HCl Oral manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Amantadine HCl Oral Market Report

Report Metric	Details
Report Name	Amantadine HCl Oral Market
Segment by Type	Tablet Capsules Syrup
Segment by Application	Parkinson's Disease Influenza
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Zydus Pharmaceuticals, Mylan, Teva, Vertical Pharmaceuticals, Adamas Pharmaceuticals, Upsher-Smith, Sandoz, Mikart Pharmaceuticals, Pharmaceutical Associates, Inc. (PAI), Wockhardt Bio AG, CMP Pharma, Bionpharma, Graviti Pharma, Alembic Pharmaceuticals, Strides Pharma, Heritage Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Amantadine HCl Oral manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Amantadine HCl Oral in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Amantadine HCl Oral Market report?

Ans: The main players in the Amantadine HCl Oral Market are Zydus Pharmaceuticals, Mylan, Teva, Vertical Pharmaceuticals, Adamas Pharmaceuticals, Upsher-Smith, Sandoz, Mikart Pharmaceuticals, Pharmaceutical Associates, Inc. (PAI), Wockhardt Bio AG, CMP Pharma, Bionpharma, Graviti Pharma, Alembic Pharmaceuticals, Strides Pharma, Heritage Pharmaceuticals

What are the Application segmentation covered in the Amantadine HCl Oral Market report?

Ans: The Applications covered in the Amantadine HCl Oral Market report are Parkinson's Disease, Influenza

What are the Type segmentation covered in the Amantadine HCl Oral Market report?

Ans: The Types covered in the Amantadine HCl Oral Market report are Tablet, Capsules, Syrup

1 Amantadine HCl Oral Market Overview

1.1 Product Definition

1.2 Amantadine HCl Oral by Type

1.2.1 Global Amantadine HCl Oral Market Value Comparison by Type (2024 VS 2031)

1.2.2 Tablet

1.2.3 Capsules

1.2.4 Syrup

1.3 Amantadine HCl Oral by Application

1.3.1 Global Amantadine HCl Oral Market Value by Application (2024 VS 2031)

1.3.2 Parkinson's Disease

1.3.3 Influenza

1.4 Global Amantadine HCl Oral Market Size Estimates and Forecasts

1.4.1 Global Amantadine HCl Oral Revenue 2020-2031

1.4.2 Global Amantadine HCl Oral Sales 2020-2031

1.4.3 Global Amantadine HCl Oral Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Amantadine HCl Oral Market Competition by Manufacturers

2.1 Global Amantadine HCl Oral Sales Market Share by Manufacturers (2020-2025)

2.2 Global Amantadine HCl Oral Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Amantadine HCl Oral Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Amantadine HCl Oral, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Amantadine HCl Oral, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Amantadine HCl Oral, Product Type & Application

2.7 Global Key Manufacturers of Amantadine HCl Oral, Date of Enter into This Industry

2.8 Global Amantadine HCl Oral Market Competitive Situation and Trends

2.8.1 Global Amantadine HCl Oral Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Amantadine HCl Oral Players Market Share by Revenue

2.8.3 Global Amantadine HCl Oral Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Amantadine HCl Oral Market Scenario by Region

3.1 Global Amantadine HCl Oral Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Amantadine HCl Oral Sales by Region: 2020-2031

3.2.1 Global Amantadine HCl Oral Sales by Region: 2020-2025

3.2.2 Global Amantadine HCl Oral Sales by Region: 2026-2031

3.3 Global Amantadine HCl Oral Revenue by Region: 2020-2031

3.3.1 Global Amantadine HCl Oral Revenue by Region: 2020-2025

3.3.2 Global Amantadine HCl Oral Revenue by Region: 2026-2031

3.4 North America Amantadine HCl Oral Market Facts & Figures by Country

3.4.1 North America Amantadine HCl Oral Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Amantadine HCl Oral Sales by Country (2020-2031)

3.4.3 North America Amantadine HCl Oral Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Amantadine HCl Oral Market Facts & Figures by Country

3.5.1 Europe Amantadine HCl Oral Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Amantadine HCl Oral Sales by Country (2020-2031)

3.5.3 Europe Amantadine HCl Oral Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Amantadine HCl Oral Market Facts & Figures by Region

3.6.1 Asia Pacific Amantadine HCl Oral Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Amantadine HCl Oral Sales by Region (2020-2031)

3.6.3 Asia Pacific Amantadine HCl Oral Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Amantadine HCl Oral Market Facts & Figures by Country

3.7.1 Latin America Amantadine HCl Oral Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Amantadine HCl Oral Sales by Country (2020-2031)

3.7.3 Latin America Amantadine HCl Oral Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Amantadine HCl Oral Market Facts & Figures by Country

3.8.1 Middle East and Africa Amantadine HCl Oral Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Amantadine HCl Oral Sales by Country (2020-2031)

3.8.3 Middle East and Africa Amantadine HCl Oral Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Amantadine HCl Oral Sales by Type (2020-2031)

4.1.1 Global Amantadine HCl Oral Sales by Type (2020-2025)

4.1.2 Global Amantadine HCl Oral Sales by Type (2026-2031)

4.1.3 Global Amantadine HCl Oral Sales Market Share by Type (2020-2031)

4.2 Global Amantadine HCl Oral Revenue by Type (2020-2031)

4.2.1 Global Amantadine HCl Oral Revenue by Type (2020-2025)

4.2.2 Global Amantadine HCl Oral Revenue by Type (2026-2031)

4.2.3 Global Amantadine HCl Oral Revenue Market Share by Type (2020-2031)

4.3 Global Amantadine HCl Oral Price by Type (2020-2031)

5 Segment by Application

5.1 Global Amantadine HCl Oral Sales by Application (2020-2031)

5.1.1 Global Amantadine HCl Oral Sales by Application (2020-2025)

5.1.2 Global Amantadine HCl Oral Sales by Application (2026-2031)

5.1.3 Global Amantadine HCl Oral Sales Market Share by Application (2020-2031)

5.2 Global Amantadine HCl Oral Revenue by Application (2020-2031)

5.2.1 Global Amantadine HCl Oral Revenue by Application (2020-2025)

5.2.2 Global Amantadine HCl Oral Revenue by Application (2026-2031)

5.2.3 Global Amantadine HCl Oral Revenue Market Share by Application (2020-2031)

5.3 Global Amantadine HCl Oral Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Zydus Pharmaceuticals

6.1.1 Zydus Pharmaceuticals Company Information

6.1.2 Zydus Pharmaceuticals Description and Business Overview

6.1.3 Zydus Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Zydus Pharmaceuticals Amantadine HCl Oral Product Portfolio

6.1.5 Zydus Pharmaceuticals Recent Developments/Updates

6.2 Mylan

6.2.1 Mylan Company Information

6.2.2 Mylan Description and Business Overview

6.2.3 Mylan Amantadine HCl Oral Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Mylan Amantadine HCl Oral Product Portfolio

6.2.5 Mylan Recent Developments/Updates

6.3 Teva

6.3.1 Teva Company Information

6.3.2 Teva Description and Business Overview

6.3.3 Teva Amantadine HCl Oral Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Teva Amantadine HCl Oral Product Portfolio

6.3.5 Teva Recent Developments/Updates

6.4 Vertical Pharmaceuticals

6.4.1 Vertical Pharmaceuticals Company Information

6.4.2 Vertical Pharmaceuticals Description and Business Overview

6.4.3 Vertical Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Vertical Pharmaceuticals Amantadine HCl Oral Product Portfolio

6.4.5 Vertical Pharmaceuticals Recent Developments/Updates

6.5 Adamas Pharmaceuticals

6.5.1 Adamas Pharmaceuticals Company Information

6.5.2 Adamas Pharmaceuticals Description and Business Overview

6.5.3 Adamas Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Adamas Pharmaceuticals Amantadine HCl Oral Product Portfolio

6.5.5 Adamas Pharmaceuticals Recent Developments/Updates

6.6 Upsher-Smith

6.6.1 Upsher-Smith Company Information

6.6.2 Upsher-Smith Description and Business Overview

6.6.3 Upsher-Smith Amantadine HCl Oral Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Upsher-Smith Amantadine HCl Oral Product Portfolio

6.6.5 Upsher-Smith Recent Developments/Updates

6.7 Sandoz

6.7.1 Sandoz Company Information

6.7.2 Sandoz Description and Business Overview

6.7.3 Sandoz Amantadine HCl Oral Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Sandoz Amantadine HCl Oral Product Portfolio

6.7.5 Sandoz Recent Developments/Updates

6.8 Mikart Pharmaceuticals

6.8.1 Mikart Pharmaceuticals Company Information

6.8.2 Mikart Pharmaceuticals Description and Business Overview

6.8.3 Mikart Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Mikart Pharmaceuticals Amantadine HCl Oral Product Portfolio

6.8.5 Mikart Pharmaceuticals Recent Developments/Updates

6.9 Pharmaceutical Associates, Inc. (PAI)

6.9.1 Pharmaceutical Associates, Inc. (PAI) Company Information

6.9.2 Pharmaceutical Associates, Inc. (PAI) Description and Business Overview

6.9.3 Pharmaceutical Associates, Inc. (PAI) Amantadine HCl Oral Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Pharmaceutical Associates, Inc. (PAI) Amantadine HCl Oral Product Portfolio

6.9.5 Pharmaceutical Associates, Inc. (PAI) Recent Developments/Updates

6.10 Wockhardt Bio AG

6.10.1 Wockhardt Bio AG Company Information

6.10.2 Wockhardt Bio AG Description and Business Overview

6.10.3 Wockhardt Bio AG Amantadine HCl Oral Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Wockhardt Bio AG Amantadine HCl Oral Product Portfolio

6.10.5 Wockhardt Bio AG Recent Developments/Updates

6.11 CMP Pharma

6.11.1 CMP Pharma Company Information

6.11.2 CMP Pharma Description and Business Overview

6.11.3 CMP Pharma Amantadine HCl Oral Sales, Revenue and Gross Margin (2020-2025)

6.11.4 CMP Pharma Amantadine HCl Oral Product Portfolio

6.11.5 CMP Pharma Recent Developments/Updates

6.12 Bionpharma

6.12.1 Bionpharma Company Information

6.12.2 Bionpharma Description and Business Overview

6.12.3 Bionpharma Amantadine HCl Oral Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Bionpharma Amantadine HCl Oral Product Portfolio

6.12.5 Bionpharma Recent Developments/Updates

6.13 Graviti Pharma

6.13.1 Graviti Pharma Company Information

6.13.2 Graviti Pharma Description and Business Overview

6.13.3 Graviti Pharma Amantadine HCl Oral Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Graviti Pharma Amantadine HCl Oral Product Portfolio

6.13.5 Graviti Pharma Recent Developments/Updates

6.14 Alembic Pharmaceuticals

6.14.1 Alembic Pharmaceuticals Company Information

6.14.2 Alembic Pharmaceuticals Description and Business Overview

6.14.3 Alembic Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Alembic Pharmaceuticals Amantadine HCl Oral Product Portfolio

6.14.5 Alembic Pharmaceuticals Recent Developments/Updates

6.15 Strides Pharma

6.15.1 Strides Pharma Company Information

6.15.2 Strides Pharma Description and Business Overview

6.15.3 Strides Pharma Amantadine HCl Oral Sales, Revenue and Gross Margin (2020-2025)

6.15.4 Strides Pharma Amantadine HCl Oral Product Portfolio

6.15.5 Strides Pharma Recent Developments/Updates

6.16 Heritage Pharmaceuticals

6.16.1 Heritage Pharmaceuticals Company Information

6.16.2 Heritage Pharmaceuticals Description and Business Overview

6.16.3 Heritage Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2020-2025)

6.16.4 Heritage Pharmaceuticals Amantadine HCl Oral Product Portfolio

6.16.5 Heritage Pharmaceuticals Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Amantadine HCl Oral Industry Chain Analysis

7.2 Amantadine HCl Oral Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Amantadine HCl Oral Production Mode & Process Analysis

7.4 Amantadine HCl Oral Sales and Marketing

7.4.1 Amantadine HCl Oral Sales Channels

7.4.2 Amantadine HCl Oral Distributors

7.5 Amantadine HCl Oral Customer Analysis

8 Amantadine HCl Oral Market Dynamics

8.1 Amantadine HCl Oral Industry Trends

8.2 Amantadine HCl Oral Market Drivers

8.3 Amantadine HCl Oral Market Challenges

8.4 Amantadine HCl Oral Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Zydus Pharmaceuticals

Mylan NV

TEVA

Vertical Pharmaceuticals

Adamas Pharmaceuticals

Upsher-Smith

Sandoz Inc

Mikart Pharmaceuticals

Pharmaceutical Associates, Inc. (PAI)

Alembic Pharmaceuticals

Strides Pharma

Heritage Pharmaceuticals

List of Tables

Table 1. Global Amantadine HCl Oral Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Amantadine HCl Oral Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Amantadine HCl Oral Market Competitive Situation by Manufacturers in 2024

Table 4. Global Amantadine HCl Oral Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Amantadine HCl Oral Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Amantadine HCl Oral Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Amantadine HCl Oral Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Amantadine HCl Oral Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Amantadine HCl Oral, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Amantadine HCl Oral, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Amantadine HCl Oral, Product Type & Application

Table 12. Global Key Manufacturers of Amantadine HCl Oral, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Amantadine HCl Oral by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amantadine HCl Oral as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Amantadine HCl Oral Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Amantadine HCl Oral Sales by Region (2020-2025) & (K Units)

Table 18. Global Amantadine HCl Oral Sales Market Share by Region (2020-2025)

Table 19. Global Amantadine HCl Oral Sales by Region (2026-2031) & (K Units)

Table 20. Global Amantadine HCl Oral Sales Market Share by Region (2026-2031)

Table 21. Global Amantadine HCl Oral Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Amantadine HCl Oral Revenue Market Share by Region (2020-2025)

Table 23. Global Amantadine HCl Oral Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Amantadine HCl Oral Revenue Market Share by Region (2026-2031)

Table 25. North America Amantadine HCl Oral Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Amantadine HCl Oral Sales by Country (2020-2025) & (K Units)

Table 27. North America Amantadine HCl Oral Sales by Country (2026-2031) & (K Units)

Table 28. North America Amantadine HCl Oral Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Amantadine HCl Oral Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Amantadine HCl Oral Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Amantadine HCl Oral Sales by Country (2020-2025) & (K Units)

Table 32. Europe Amantadine HCl Oral Sales by Country (2026-2031) & (K Units)

Table 33. Europe Amantadine HCl Oral Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Amantadine HCl Oral Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Amantadine HCl Oral Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Amantadine HCl Oral Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Amantadine HCl Oral Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Amantadine HCl Oral Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Amantadine HCl Oral Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Amantadine HCl Oral Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Amantadine HCl Oral Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Amantadine HCl Oral Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Amantadine HCl Oral Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Amantadine HCl Oral Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Amantadine HCl Oral Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Amantadine HCl Oral Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Amantadine HCl Oral Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Amantadine HCl Oral Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Amantadine HCl Oral Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Amantadine HCl Oral Sales (K Units) by Type (2020-2025)

Table 51. Global Amantadine HCl Oral Sales (K Units) by Type (2026-2031)

Table 52. Global Amantadine HCl Oral Sales Market Share by Type (2020-2025)

Table 53. Global Amantadine HCl Oral Sales Market Share by Type (2026-2031)

Table 54. Global Amantadine HCl Oral Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Amantadine HCl Oral Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Amantadine HCl Oral Revenue Market Share by Type (2020-2025)

Table 57. Global Amantadine HCl Oral Revenue Market Share by Type (2026-2031)

Table 58. Global Amantadine HCl Oral Price (USD/Unit) by Type (2020-2025)

Table 59. Global Amantadine HCl Oral Price (USD/Unit) by Type (2026-2031)

Table 60. Global Amantadine HCl Oral Sales (K Units) by Application (2020-2025)

Table 61. Global Amantadine HCl Oral Sales (K Units) by Application (2026-2031)

Table 62. Global Amantadine HCl Oral Sales Market Share by Application (2020-2025)

Table 63. Global Amantadine HCl Oral Sales Market Share by Application (2026-2031)

Table 64. Global Amantadine HCl Oral Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Amantadine HCl Oral Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Amantadine HCl Oral Revenue Market Share by Application (2020-2025)

Table 67. Global Amantadine HCl Oral Revenue Market Share by Application (2026-2031)

Table 68. Global Amantadine HCl Oral Price (USD/Unit) by Application (2020-2025)

Table 69. Global Amantadine HCl Oral Price (USD/Unit) by Application (2026-2031)

Table 70. Zydus Pharmaceuticals Company Information

Table 71. Zydus Pharmaceuticals Description and Business Overview

Table 72. Zydus Pharmaceuticals Amantadine HCl Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Zydus Pharmaceuticals Amantadine HCl Oral Product

Table 74. Zydus Pharmaceuticals Recent Developments/Updates

Table 75. Mylan Company Information

Table 76. Mylan Description and Business Overview

Table 77. Mylan Amantadine HCl Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Mylan Amantadine HCl Oral Product

Table 79. Mylan Recent Developments/Updates

Table 80. Teva Company Information

Table 81. Teva Description and Business Overview

Table 82. Teva Amantadine HCl Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Teva Amantadine HCl Oral Product

Table 84. Teva Recent Developments/Updates

Table 85. Vertical Pharmaceuticals Company Information

Table 86. Vertical Pharmaceuticals Description and Business Overview

Table 87. Vertical Pharmaceuticals Amantadine HCl Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Vertical Pharmaceuticals Amantadine HCl Oral Product

Table 89. Vertical Pharmaceuticals Recent Developments/Updates

Table 90. Adamas Pharmaceuticals Company Information

Table 91. Adamas Pharmaceuticals Description and Business Overview

Table 92. Adamas Pharmaceuticals Amantadine HCl Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Adamas Pharmaceuticals Amantadine HCl Oral Product

Table 94. Adamas Pharmaceuticals Recent Developments/Updates

Table 95. Upsher-Smith Company Information

Table 96. Upsher-Smith Description and Business Overview

Table 97. Upsher-Smith Amantadine HCl Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Upsher-Smith Amantadine HCl Oral Product

Table 99. Upsher-Smith Recent Developments/Updates

Table 100. Sandoz Company Information

Table 101. Sandoz Description and Business Overview

Table 102. Sandoz Amantadine HCl Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Sandoz Amantadine HCl Oral Product

Table 104. Sandoz Recent Developments/Updates

Table 105. Mikart Pharmaceuticals Company Information

Table 106. Mikart Pharmaceuticals Description and Business Overview

Table 107. Mikart Pharmaceuticals Amantadine HCl Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Mikart Pharmaceuticals Amantadine HCl Oral Product

Table 109. Mikart Pharmaceuticals Recent Developments/Updates

Table 110. Pharmaceutical Associates, Inc. (PAI) Company Information

Table 111. Pharmaceutical Associates, Inc. (PAI) Description and Business Overview

Table 112. Pharmaceutical Associates, Inc. (PAI) Amantadine HCl Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Pharmaceutical Associates, Inc. (PAI) Amantadine HCl Oral Product

Table 114. Pharmaceutical Associates, Inc. (PAI) Recent Developments/Updates

Table 115. Wockhardt Bio AG Company Information

Table 116. Wockhardt Bio AG Description and Business Overview

Table 117. Wockhardt Bio AG Amantadine HCl Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. Wockhardt Bio AG Amantadine HCl Oral Product

Table 119. Wockhardt Bio AG Recent Developments/Updates

Table 120. CMP Pharma Company Information

Table 121. CMP Pharma Description and Business Overview

Table 122. CMP Pharma Amantadine HCl Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 123. CMP Pharma Amantadine HCl Oral Product

Table 124. CMP Pharma Recent Developments/Updates

Table 125. Bionpharma Company Information

Table 126. Bionpharma Description and Business Overview

Table 127. Bionpharma Amantadine HCl Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 128. Bionpharma Amantadine HCl Oral Product

Table 129. Bionpharma Recent Developments/Updates

Table 130. Graviti Pharma Company Information

Table 131. Graviti Pharma Description and Business Overview

Table 132. Graviti Pharma Amantadine HCl Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 133. Graviti Pharma Amantadine HCl Oral Product

Table 134. Graviti Pharma Recent Developments/Updates

Table 135. Alembic Pharmaceuticals Company Information

Table 136. Alembic Pharmaceuticals Description and Business Overview

Table 137. Alembic Pharmaceuticals Amantadine HCl Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 138. Alembic Pharmaceuticals Amantadine HCl Oral Product

Table 139. Alembic Pharmaceuticals Recent Developments/Updates

Table 140. Strides Pharma Company Information

Table 141. Strides Pharma Description and Business Overview

Table 142. Strides Pharma Amantadine HCl Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 143. Strides Pharma Amantadine HCl Oral Product

Table 144. Strides Pharma Recent Developments/Updates

Table 145. Heritage Pharmaceuticals Company Information

Table 146. Heritage Pharmaceuticals Description and Business Overview

Table 147. Heritage Pharmaceuticals Amantadine HCl Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 148. Heritage Pharmaceuticals Amantadine HCl Oral Product

Table 149. Heritage Pharmaceuticals Recent Developments/Updates

Table 150. Key Raw Materials Lists

Table 151. Raw Materials Key Suppliers Lists

Table 152. Amantadine HCl Oral Distributors List

Table 153. Amantadine HCl Oral Customers List

Table 154. Amantadine HCl Oral Market Trends

Table 155. Amantadine HCl Oral Market Drivers

Table 156. Amantadine HCl Oral Market Challenges

Table 157. Amantadine HCl Oral Market Restraints

Table 158. Research Programs/Design for This Report

Table 159. Key Data Information from Secondary Sources

Table 160. Key Data Information from Primary Sources

Table 161. Authors List of This Report

List of Figures

Figure 1. Product Picture of Amantadine HCl Oral

Figure 2. Global Amantadine HCl Oral Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Amantadine HCl Oral Market Share by Type: 2024 & 2031

Figure 4. Tablet Product Picture

Figure 5. Capsules Product Picture

Figure 6. Syrup Product Picture

Figure 7. Global Amantadine HCl Oral Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Amantadine HCl Oral Market Share by Application: 2024 & 2031

Figure 9. Parkinson's Disease

Figure 10. Influenza

Figure 11. Global Amantadine HCl Oral Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Amantadine HCl Oral Market Size (2020-2031) & (US$ Million)

Figure 13. Global Amantadine HCl Oral Sales (2020-2031) & (K Units)

Figure 14. Global Amantadine HCl Oral Average Price (USD/Unit) & (2020-2031)

Figure 15. Amantadine HCl Oral Report Years Considered

Figure 16. Amantadine HCl Oral Sales Share by Manufacturers in 2024

Figure 17. Global Amantadine HCl Oral Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Amantadine HCl Oral Players: Market Share by Revenue in Amantadine HCl Oral in 2024

Figure 19. Amantadine HCl Oral Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Amantadine HCl Oral Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Amantadine HCl Oral Sales Market Share by Country (2020-2031)

Figure 22. North America Amantadine HCl Oral Revenue Market Share by Country (2020-2031)

Figure 23. U.S. Amantadine HCl Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Amantadine HCl Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Amantadine HCl Oral Sales Market Share by Country (2020-2031)

Figure 26. Europe Amantadine HCl Oral Revenue Market Share by Country (2020-2031)

Figure 27. Germany Amantadine HCl Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Amantadine HCl Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Amantadine HCl Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Amantadine HCl Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Amantadine HCl Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Amantadine HCl Oral Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Amantadine HCl Oral Revenue Market Share by Region (2020-2031)

Figure 34. China Amantadine HCl Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Amantadine HCl Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Amantadine HCl Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Amantadine HCl Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Amantadine HCl Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Taiwan Amantadine HCl Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Indonesia Amantadine HCl Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Thailand Amantadine HCl Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Malaysia Amantadine HCl Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Philippines Amantadine HCl Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Latin America Amantadine HCl Oral Sales Market Share by Country (2020-2031)

Figure 45. Latin America Amantadine HCl Oral Revenue Market Share by Country (2020-2031)

Figure 46. Mexico Amantadine HCl Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Brazil Amantadine HCl Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Argentina Amantadine HCl Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Middle East and Africa Amantadine HCl Oral Sales Market Share by Country (2020-2031)

Figure 50. Middle East and Africa Amantadine HCl Oral Revenue Market Share by Country (2020-2031)

Figure 51. Turkey Amantadine HCl Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia Amantadine HCl Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. UAE Amantadine HCl Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Global Sales Market Share of Amantadine HCl Oral by Type (2020-2031)

Figure 55. Global Revenue Market Share of Amantadine HCl Oral by Type (2020-2031)

Figure 56. Global Amantadine HCl Oral Price (USD/Unit) by Type (2020-2031)

Figure 57. Global Sales Market Share of Amantadine HCl Oral by Application (2020-2031)

Figure 58. Global Revenue Market Share of Amantadine HCl Oral by Application (2020-2031)

Figure 59. Global Amantadine HCl Oral Price (USD/Unit) by Application (2020-2031)

Figure 60. Amantadine HCl Oral Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions